AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12377352
Drug: Dose-volume histograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-volume histograms (DVH) for an eccentric seed train
Trial: 7926342
Drug: Multiple injections
RxNorm normalized name: sodium acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple injections (4‐6 times daily)
Trial: 7926342
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (twice daily)
Trial: 2573264
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg daily (AT 50)
Trial: 2573264
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg daily (AT 100)
Trial: 2573264
Drug: Propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 80 mg twice a day (Prop)
Trial: 28228317
Drug: SAXA-MET (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAXA-MET (5 mg/2,000 mg)
Trial: 28228317
Drug: MET (2,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MET (2,000 mg)
Trial: 28228317
Drug: SAXA (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAXA (5 mg)
Trial: 22108474
Drug: Silver Oxide
RxNorm normalized name: Silver Oxide
DrugBank: Silver oxide (DB15668)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver Oxide Ointment
Trial: 19370045
Drug: 16.6 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16.6 g of whey protein + 3.4 g of leucine (W+L)
Trial: 15378556
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg divalproex sodium extended-release (divalproex-ER)
Trial: 15378556
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg divalproex sodium extended-release (divalproex-ER)
Trial: 11387490
Drug: Ultrasound contrast
RxNorm normalized name: ULTRASOUND CONTRAST MEDIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound contrast agent (Levovist, 300 mg/mL, 1 mL/min)
Trial: 11387490
Drug: No ultrasound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ultrasound contrast agent (USCA)
Trial: 11387490
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of USCA
Trial: 9409267
Drug: Endothelin-1 (ET-1)
RxNorm normalized name: nitric oxide synthase endothelial
DrugBank: Endothelin-1 (DB12652)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endothelin-1 (ET-1) administered intravenously for 6 hours
Trial: 9409267
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered intravenously for 6 hours
Trial: 8494374
Drug: Intensive aluminum‐magnesium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive aluminum‐magnesium hydroxide antacid regimen (Maalox TC) administered at multiple time points relative to enoxacin infusion.
Trial: 8494374
Drug: Intravenous enoxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous enoxacin (400 mg) administered without antacid treatment.
Trial: 3317784
Drug: Budesonide enema,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide enema, 2 mg/100 ml
Trial: 3317784
Drug: Prednisolone disodium
RxNorm normalized name: BALSALAZIDE DISODIUM
DrugBank: Balsalazide (DB01014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone disodium phosphate enema, 31.25 mg/100 ml
Trial: 28211882
Drug: Aflibercept (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aflibercept (2 mg) administered as three monthly intravitreal injections followed by two bi-monthly injections and a final examination at week 28.
Trial: 21464563
Drug: Ultrasound-assisted wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-assisted wound treatment (UAW)
Trial: 18493214
Drug: Long-chain polyunsaturated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-chain polyunsaturated fatty acids (LCPUFAs) supplementation (AA: 20-30 mg daily, DHA: 14-21 mg daily)
Trial: 16566900
Drug: Fludrocortisone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone (0.5 mg)
Trial: 9089582
Drug: liposome-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: liposome-adjuvanted vaccine
Trial: 9089582
Drug: control subvirion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: control subvirion vaccine
Trial: 1337623
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg lomefloxacin once daily for 3 days (L3)
Trial: 1337623
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg lomefloxacin once daily for 7 days (L7)
Trial: 1337623
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg norfloxacin twice daily for 7 days (N7)
Trial: 31479209
Drug: Standard-treatment group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-treatment group (ticagrelor or prasugrel)
Trial: 27465112
Drug: Education plus
RxNorm normalized name: salicylic acid Medicated Shampoo [Ionil Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education plus decolonization without reminders (intranasal mupirocin ointment twice daily for 7 days and chlorhexidine gluconate on the first and last day)
Trial: 27465112
Drug: Education plus
RxNorm normalized name: salicylic acid Medicated Shampoo [Ionil Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education plus decolonization with reminders (daily telephone call or text message reminders)
Trial: 17043094
Drug: Arm B
RxNorm normalized name: arm brace
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B (weekly): gemcitabine 1000 mg/m2 and paclitaxel 100 mg/m2 on days 1 and 8 of a 21-day cycle
Trial: 17043094
Drug: Arm A
RxNorm normalized name: Warm antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm A (three-weekly): gemcitabine 1000 mg/m2 on days 1 and 8 and paclitaxel 200 mg/m2 on day 1 of a 21-day cycle
Trial: 16253098
Drug: SRP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP and 400 mg systemically administered metronidazole (MET) three times per day for 10 days
Trial: 10640634
Drug: Reciprocally organized
RxNorm normalized name: Organic germanium
DrugBank: Propagermanium (DB17608)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reciprocally organized agonist and antagonist muscle activity
Trial: 27269279
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (0.2 mg/ml)
Trial: 31472446
Drug: Metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 850 mg po bid
Trial: 30325687
Drug: HTP (hyaluronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HTP (hyaluronic acid-based topical lubricant)
Trial: 22975536
Drug: Methimazole +
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole + β‐blockers
Trial: 22975536
Drug: Methimazole without
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole without β‐blockers
Trial: 15857284
Drug: Brinzolamide 1%
RxNorm normalized name: BRINZOLAMIDE 1% SUSP,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brinzolamide 1% (twice a day)
Trial: 26483224
Drug: Montelukast (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (4 mg once a day for 7 days)
Trial: 26483224
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (routine medical treatment only)
Trial: 23596782
Drug: Shugan Jianpi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shugan Jianpi Gusui Recipe (SJGR) administered during the remission phase
Trial: 23596782
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treated with azathioprine alone or no treatment
Trial: 21331063
Drug: Insulin Resistant
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin Resistant (IR) group
Trial: 16334719
Drug: Zishen Tongli
RxNorm normalized name: ALCOHOL 42 mL in 60 mL TOPICAL GEL [TongYi CleanGuard Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zishen Tongli Jiaonang (capsules for nourishing the kidney and promoting urination)
Trial: 16334719
Drug: Antibiotics according
RxNorm normalized name: clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotics according to drug sensitive tests (control group)
Trial: 28692407
Drug: Residential treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Residential treatment
Trial: 19015420
Drug: Indigo naturalis
RxNorm normalized name: indigo
DrugBank: Indigo (DB16862)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indigo naturalis ointment
Trial: 10711101
Drug: Regular daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular daily telephone call reminders
Trial: 10711101
Drug: Daily videotelephone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily videotelephone call reminders
Trial: 7477807
Drug: Vitamin supplementation
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin supplementation (10 times the recommended daily dose of 9 vitamins)
Trial: 8724065
Drug: Pneumococcal glycoprotein
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal glycoprotein conjugate vaccine (primary immunization)
Trial: 8724065
Drug: Pneumococcal polysaccharide
RxNorm normalized name: pneumococcal polysaccharides (23)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal polysaccharide vaccine (secondary immunization)
Trial: 1929247
Drug: Amoxicillin-clavulanate, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanate, 1 g plus 250 mg per os every 12 h for 3 days
Trial: 1929247
Drug: Amoxicillin-clavulanate, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanate, 1 g plus 250 mg per os every 12 h on day 3 only (1-day regimen)
Trial: 29973284
Drug: High-dose JWYH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose JWYH plus usual care
Trial: 29973284
Drug: Low-dose JWYH
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose JWYH plus usual care
Trial: 26277174
Drug: HILT laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HILT laser therapy
Trial: 20936417
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (400 mg, twice daily)
Trial: 19003734
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg vitamin C supplementation
Trial: 3886142
Drug: Guanfacine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine (1 mg/day, once daily)
Trial: 3886142
Drug: Guanfacine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine (2.5 mg/day, once daily)
Trial: 3886142
Drug: Methyldopa (763
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (763 mg/day, twice daily)
Trial: 3886142
Drug: Guanfacine (continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine (continued therapy for one year)
Trial: 29628009
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of aprotinin
Trial: 18517077
Drug: Oral fexofenadine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fexofenadine (180 mg)
Trial: 18517077
Drug: Oral diphenhydramine
RxNorm normalized name: diphenhydramine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diphenhydramine (50 mg)
Trial: 18517077
Drug: Intramuscular diphenhydramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular diphenhydramine (50 mg)
Trial: 16043675
Drug: Testosterone patch
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone patch 300 microg/d
Trial: 16043675
Drug: Testosterone patch
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone patch 150 microg/d
Trial: 16043675
Drug: Testosterone patch
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone patch 450 microg/d
Trial: 12427118
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human enzyme, alpha-galactosidase A (r-halalphaGalA), administered IV at 1 mg/kg biweekly for 11 months
Trial: 482028
Drug: Intradimensional oddity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradimensional oddity shift (CC group)
Trial: 31646969
Drug: PGB diluted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGB diluted with 0.5 mL mepivacaine 1% and long 19G needle
Trial: 31646969
Drug: PGB diluted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGB diluted with 0.5 mL mepivacaine 1% and short 21G needle
Trial: 25816805
Drug: 1.7 g
RxNorm normalized name: Vaporizer 1.7 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.7 g n‐3 PUFA daily for 3 months
Trial: 17701133
Drug: Rebamipide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rebamipide (100 mg for 7 weeks)
Trial: 15251636
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy aiming for strict normoglycemia (80 to 110 mg/dL or 4.5 to 6.1 mmol/L) during intensive care
Trial: 11054443
Drug: Antibiotic regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic regimen A
Trial: 11054443
Drug: Antibiotic regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic regimen B
Trial: 8455332
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg OFLX once daily
Trial: 8455332
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg OFLX three times daily
Trial: 3513519
Drug: Verapamil (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (120 to 240 mg 2 times a day)
Trial: 3513519
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 to 240 mg 2 times a day)
Trial: 3513519
Drug: Both drugs
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both drugs (Verapamil and Propranolol)
Trial: 31515458
Drug: Anti-EGFR antibody
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-EGFR antibody treatment (n = 12 class 2, n = 28 class 3)
Trial: 31515458
Drug: First- or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First- or second-line anti-EGFR therapy
Trial: 31515458
Drug: Third- or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third- or later-line anti-EGFR therapy
Trial: 28095527
Drug: One dental
RxNorm normalized name: carbenoxolone Dental Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One dental implant
Trial: 28095527
Drug: Two dental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two dental implants
Trial: 28095527
Drug: One or
RxNorm normalized name: Geone Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One or two dental implants
Trial: 12006526
Drug: Anthracycline-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline-based therapy (HEC)
Trial: 12006526
Drug: Anthracycline-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline-based therapy (EC)
Trial: 9819447
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b plus ribavirin (1000 to 1200 mg orally per day for six months)
Trial: 7667050
Drug: Clarithromycin suspension
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin suspension 15 mg/kg/day divided twice a day
Trial: 7667050
Drug: Erythromycin suspension
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin suspension 40 mg/kg/day divided twice or three times a day
Trial: 2468932
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg SK&F 86466
Trial: 2468932
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg SK&F 86466
Trial: 2468932
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg SK&F 86466
Trial: 21288351
Drug: Sevelamer carbonate
RxNorm normalized name: Sevelamer Carbonate
DrugBank: Sevelamer (DB00658)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevelamer carbonate (1600 mg with meals for 4 weeks, then randomized to continue for 36 weeks)
Trial: 18727661
Drug: On‐St group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On‐St group (patients on steroids at 15th day after transplantation)
Trial: 18727661
Drug: Off‐St group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Off‐St group (patients not on steroids at 15th day after transplantation)
Trial: 16452695
Drug: Assertive Community
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assertive Community Treatment
Trial: 15323594
Drug: Fluoxetine dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine dose increase
Trial: 15323594
Drug: Lithium augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium augmentation of fluoxetine
Trial: 15323594
Drug: Desipramine augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine augmentation of fluoxetine
Trial: 11732814
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide nasal spray (IBNS) 80 microg twice per day (b.i.d.)
Trial: 9417265
Drug: NaCl bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl bolus injection (20 ml)
Trial: 9417265
Drug: Body mass
RxNorm normalized name: Total Body Massager Item
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body mass index, injection flow, and contrast material volume
Trial: 7525120
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily GH injection (3 IU/m2/24 h in the evening)
Trial: 7525120
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily GH injections (3 IU/m2, two-thirds in the evening and one-third in the morning)
Trial: 7525120
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily GH injection
Trial: 7525120
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily GH injections
Trial: 3116111
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of paracetamol
Trial: 3116111
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg of diflunisal
Trial: 3116111
Drug: First and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First and second doses of paracetamol
Trial: 3116111
Drug: First and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First and second doses of diflunisal
Trial: 27659879
Drug: CSL112 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSL112 (2 g)
Trial: 19038899
Drug: Celecoxib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (200 or 400 mg daily)
Trial: 10871568
Drug: Carb +
RxNorm normalized name: Carb-O-Lac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carb + Pro trial (0.8 g carbohydrate*kg(‐)(1)*h(‐)(1) plus 0.4 g wheat protein hydrolysate plus free leucine and phenylalanine*kg(‐)(1)*h(‐)(1))
Trial: 10871568
Drug: Carb +
RxNorm normalized name: Carb-O-Lac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carb + Carb trial (1.2 g carbohydrate*kg(‐)(1)*h(‐)(1))
Trial: 10871568
Drug: Carb trial
RxNorm normalized name: Carb-O-Lac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carb trial (0.8 g carbohydrate*kg(‐)(1)*h(‐)(1))
Trial: 8804876
Drug: Interferon-alpha-2b, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha-2b, 3 MU thrice weekly for 6 months (n = 26)
Trial: 8804876
Drug: Interferon-alpha-2b, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha-2b, 3 MU thrice weekly for 12 months (n = 34)
Trial: 8804876
Drug: Interferon-alpha-2b, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha-2b, 3 MU thrice weekly for 6 months
Trial: 8804876
Drug: Interferon-alpha-2b, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha-2b, 3 MU thrice weekly for 12 months
Trial: 31128228
Drug: Elevated ANP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated ANP, BNP, or Pro‐BNP (cutoffs of >77, 100, and 900 pg/mL, respectively)